Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     

  • Bitcoin GBP

    51,247.41
    -510.68 (-0.99%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Global Injectables Market (2021 to 2025) - Insights & Forecast with Potential Impact of COVID-19

Research and Markets
·6-min read

Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com's offering.

The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as the increasing geriatric population, an upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive the growth of the market. However, the market growth would be challenged by stringent regulatory guidelines, the emergence of alternative drug delivery methods and manufacturing complexity and high operational cost. A few notable trends may include the accelerating prevalence of chronic diseases, growing adoption of self-injectable devices, an upswing in drug shortages, and advancements in technology.

Depending on the type, the global injectables market can be bifurcated into two main categories: innovator and generic. Further, the generic injectables market can be split into Anti-Infectives (AI), Antineoplastics + Immunomodulators (AN+IM), Alimentary Tract + Metabolic (AT+Mb), Blood-Related (BR), Central Nervous System (CNS), Musculoskeletal (Msk) and others, on the basis of therapy.

The fastest-growing regional market is North America due to the improvements in healthcare infrastructure coupled with growing demand for injectables on account of the high presence of a large number of patients with chronic diseases such as diabetes and arthritis which require frequent drug dosing and increasing research and development activities for the development of innovative injectables drugs. However, the market experienced a neutral growth due to the outbreak of COVID-19 which moderately affected the production and clinical trials of various drugs.

ADVERTISEMENT

Scope of the report:

  • The report provides a comprehensive analysis of the global injectables market segmented on the basis of type and region.

  • The major regional and country markets (North America, Europe, China, India and Rest of the World) have been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International Inc., Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.) and Hikma Pharmaceuticals PLC) are also presented in detail.

Key Target Audience:

  • Injectable Drug Manufacturers & Distributers

  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies

  • End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers & Others)

  • Research and Development (R&D) Organizations

  • Government Bodies & Regulating Authorities

Key Topics Covered:

1. Market Overview

2. Impact of COVID-19
2.1 Growing Investments in the R&D Pipeline of Injectables
2.2 Surging Adoption of Plasma Therapy
2.3 Rising Usage of Smart Syringes
2.4 Accelerating Vaccine Production

3. Global Market Analysis
3.1 Global Injectables Market by Value
3.2 Global Injectables Market Forecast by Value
3.3 Global Injectables Market by Type
3.3.1 Global Innovator Injectables Market by Value
3.3.2 Global Innovator Injectables Market Forecast by Value
3.3.3 Global Generic Injectables Market by Value
3.3.4 Global Generic Injectables Market Forecast by Value
3.3.5 Global Generic Injectables Market by Therapy
3.3.6 Global Anti-Infective Injectables Market by Value
3.3.7 Global Anti-Infective Injectables Market Forecast by Value
3.3.8 Global Antineoplastic+ Immunomodulator Injectables Market by Value
3.3.9 Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value
3.3.10 Global Alimentary Tract + Metabolic Injectables Market by Value
3.3.11 Global Alimentary Tract + Metabolic Injectables Market Forecast by Value
3.3.12 Global Blood Related Injectables Market by Value
3.3.13 Global Blood Related Injectables Market Forecast by Value
3.3.14 Global Central Nervous System Injectables Market by Value
3.3.15 Global Central Nervous System Injectables Market Forecast by Value
3.3.16 Global Musculoskeletal Injectables Market by Value
3.3.17 Global Musculoskeletal Injectables Market Forecast by Value
3.4 Global Injectables Market by Region
3.5 Global Generic Injectables Market by Region

4. Regional Market Analysis
4.1 North America
4.1.1 North America Injectables Market by Value
4.1.2 North America Injectables Market Forecast by Value
4.1.3 North America Generic Injectables Market Forecast by Value
4.1.4 The U.S. Injectables Market by Value
4.1.5 The U.S. Injectables Market Forecast by Value
4.1.6 The U.S. Injectables Market by Type
4.1.7 The U.S. Innovator Injectables Market Forecast by Value
4.1.8 The U.S. Generic Injectables Market Forecast by Value
4.2 Europe
4.2.1 Europe Injectables Market by Value
4.2.2 Europe Injectables Market Forecast by Value
4.2.3 Europe Generic Injectables Market Forecast by Value
4.3 China
4.3.1 China Injectables Market by Value
4.3.2 China Injectables Market Forecast by Value
4.3.3 China Injectables Market by Type
4.3.4 China Generic Injectables Market Forecast by Value
4.3.5 China Innovator Injectables Market Forecast by Value
4.4 India
4.4.1 India Injectables Market by Value
4.4.2 India Injectables Market Forecast by Value
4.4.3 India Generic Injectables Market Forecast by Value
4.5 RoW
4.5.1 RoW Injectables Market by Value
4.5.2 RoW Injectables Market Forecast by Value
4.5.3 RoW Generic Injectables Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Upsurge in Demand for Convenient Drug Delivery
5.1.3 Expanding Use of Biologics
5.1.4 Rising Healthcare Expenditure
5.1.5 Surging Incidence of Cancer Cases
5.2 Key Trends and Developments
5.2.1 Accelerating Prevalence of Chronic Diseases
5.2.2 Growing Adoption of Self-Injectable Devices
5.2.3 Upswing in Drug Shortages
5.2.4 Advancements in Technology
5.3 Challenges
5.3.1 Stringent Regulatory Guidelines
5.3.2 Emergence of Alternative Drug Delivery Methods
5.3.3 Manufacturing Complexity & High Operational Cost

6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
6.2 North America Market
6.2.1 The U.S. Generic Injectables Market Value Share by Key Players
6.2.2 The U.S. Generic Injectables Market Volume Share by Key Players

7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Pfizer Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Fresenius SE & Co. KGaA
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Baxter International Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.)
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Hikma Pharmaceuticals PLC
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies

For more information about this report visit https://www.researchandmarkets.com/r/el26ux

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900